BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30522964)

  • 41. Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6.
    Zhao K; Yu L; Wang X; He Y; Lu B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):216-223. PubMed ID: 29329362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol; 2017 Jan; 52(1):72-80. PubMed ID: 27075754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
    Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.
    Zhou XY; Li M; Li X; Long X; Zuo XL; Hou XH; Cong YZ; Li YQ
    World J Gastroenterol; 2016 Jun; 22(22):5211-27. PubMed ID: 27298564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
    Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
    Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
    Eutamene H; Bradesi S; Larauche M; Theodorou V; Beaufrand C; Ohning G; Fioramonti J; Cohen M; Bryant AP; Kurtz C; Currie MG; Mayer EA; Bueno L
    Neurogastroenterol Motil; 2010 Mar; 22(3):312-e84. PubMed ID: 19706070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
    Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus.
    Lin MJ; Yu BP
    Dig Dis Sci; 2018 Dec; 63(12):3329-3338. PubMed ID: 30155840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.
    Temiz TK; Demir O; Simsek F; Kaplan YC; Bahceci S; Karadas B; Celik A; Koyluoglu G
    Indian J Pharmacol; 2016; 48(4):424-429. PubMed ID: 27756955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
    Moussa L; Bézirard V; Salvador-Cartier C; Bacquié V; Houdeau E; Théodorou V
    Clin Nutr; 2013 Feb; 32(1):51-8. PubMed ID: 22727545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.
    Wu J; Cheng Y; Zhang R; Liu D; Luo YM; Chen KL; Ren S; Zhang J
    World J Gastroenterol; 2017 Sep; 23(34):6339-6349. PubMed ID: 28974901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition.
    Moloney RD; Stilling RM; Dinan TG; Cryan JF
    Neurogastroenterol Motil; 2015 Dec; 27(12):1831-6. PubMed ID: 26403543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity.
    Liu HR; Fang XY; Wu HG; Wu LY; Li J; Weng ZJ; Guo XX; Li YG
    World J Gastroenterol; 2015 Jun; 21(23):7181-90. PubMed ID: 26109804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stress-induced intestinal barrier dysfunction is exacerbated during diet-induced obesity.
    Bahlouli W; Breton J; Lelouard M; L'Huillier C; Tirelle P; Salameh E; Amamou A; Atmani K; Goichon A; Bôle-Feysot C; Ducrotté P; Ribet D; Déchelotte P; Coëffier M
    J Nutr Biochem; 2020 Jul; 81():108382. PubMed ID: 32417626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor.
    Wan H; Yuan Y; Liu J; Chen G
    Transl Res; 2012 Aug; 160(2):153-61. PubMed ID: 22677361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.